Trials / Unknown
UnknownNCT04442828
3D Echocardiography and Cardiovascular Prognosis in Mitral Regurgitation
3D Echocardiography and Cardiovascular PRognosis In Mitral REgurgitation (3D-PRIME)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Haukeland University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The 3D-PRIME study will analyse whether use of 3D echocardiography can improve risk stratification and cardiovascular outcome in patients with mitral regurgitation of different etiologies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Use of 3D echocardiography in patient follow-up | Patients will undergo clinical and echocardiographic examination including detailed 3D echocardiography at study inclusion and at least one follow-up visit. |
Timeline
- Start date
- 2020-04-17
- Primary completion
- 2025-04-01
- Completion
- 2025-04-01
- First posted
- 2020-06-23
- Last updated
- 2023-09-25
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT04442828. Inclusion in this directory is not an endorsement.